mortality/aging
• 50% of mice survive to 26 weeks of age
|
neoplasm
• mice develop aggressive osteosarcoma with complete penetrance
• treatment of mice with RANK-Fc beginning at 17 weeks of age suppresses osteosarcoma progression and reduces lung metastasis by more than 3-fold
|
skeleton
• mice develop aggressive osteosarcoma with complete penetrance
• treatment of mice with RANK-Fc beginning at 17 weeks of age suppresses osteosarcoma progression and reduces lung metastasis by more than 3-fold
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
osteosarcoma | DOID:3347 |
OMIM:259500 |
J:234128 |